Estimate the Behavior of Chinese Anesthesiologists Practicing General Anesthesia With Sevoflurane
- Conditions
- Anesthesia, General
- Registration Number
- NCT01199471
- Lead Sponsor
- Abbott
- Brief Summary
This registry is primarily aiming to demonstrate the correlation between good practices of anesthesiologists and patient related outcomes including decreased overall anesthesia cost. The investigators would also like to demonstrate how the training background, and experience in inhalational anesthesia of the anesthesiologist influence their daily practice. At the end of the registry, the investigators would be able to demonstrate the influence of different practice pattern on patient related outcomes between the sites at which anesthesiologists follow modern anesthesiology practice based on their training/experience background and at which anesthesiologists do not follow same type of practice due to lack of their inhalational anesthesia training/experience.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 4000
- ASA (American Society of Anesthesiologists) physical status (a requirement of the patient's physical status): I to III
- Age from 18 to 70 years
- Surgery requiring general anesthesia with endotracheal intubation or laryngeal mask airway.
- History of significant cardiovascular, pulmonary, renal, hepatic or central nervous system disease or muscle disease.
- Hypersensitivity or unusual response to any halogenated anesthetics.
- Personal or familial history of malignant hyperthermia.
- Female patients either pregnant or breast feeding.
- General anesthesia is administered with total intravenous anesthesia (TIVA) of propofol.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anesthesiologist Satisfaction With the Anesthesia Recorded at the End of the Operation Using a Numeric Analog Scale (NAS) Within 24 hours Anesthesiologist satisfaction with the anesthesia administered to each patient during surgery was recorded at the end of the operation using a Numeric Analog Scale (NAS) from 0 (not satisfied at all) to 10 (completely satisfied) are summarized.
Patient Satisfaction With the Anesthesia Recorded at the End of the Operation Using a Numeric Analog Scale (NAS) Within 24 hours Patient satisfaction with the anesthesia recorded at the end of the operation within 24 hours using a numeric analog scale (NAS) from 0 (not satisfied at all) to 10 (completely satisfied) are summarized.
- Secondary Outcome Measures
Name Time Method Time to Loss of Consciousness of Patients Administered Anesthesia Up to 10 minutes The time to loss of consciousness was measured from commencement of administration of anesthesia to the patient's loss of consciousness (no response to command).
Time to Intubation of Patients Up to 10 minutes The time to intubation of the patients was measured from the commencement of administration of anesthesia to intubation of each patient.
Time to Eye Opening of Patients Every minute after cessation of anesthesia until the patient opened his/her eyes Time to eye opening of patients was measured by the time from cessation of anesthesia administration to opening of the patients' eyes. After cessation of anesthesia, the investigators lightly tapped on the patients forehead or shoulder and asked the patients to open their eyes. This process was repeated about every minute until the patients opened their eyes.
Time to Extubation of Patients Every minute after cessation of anesthesia until the patient was extubated The time to extubation of patients was measured from cessation of anesthesia administration to tracheal extubation of the patient.
Trial Locations
- Locations (40)
Site Reference ID/Investigator# 43055
🇨🇳Zhejiang, China
Site Reference ID/Investigator# 43054
🇨🇳Zhejiang, China
Site Reference ID/Investigator# 43073
🇨🇳Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43072
🇨🇳Guangzhou, Guangdong, China
Site Reference ID/Investigator# 46407
🇨🇳Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43076
🇨🇳Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43077
🇨🇳Guangzhou, Guangdong, China
Site Reference ID/Investigator# 43066
🇨🇳Harbin, Heilongjiang, China
Site Reference ID/Investigator# 43070
🇨🇳Wuhan, Hubei, China
Site Reference ID/Investigator# 43068
🇨🇳Harbin, Heilongjiang, China
Site Reference ID/Investigator# 43071
🇨🇳Wuhan, Hubei, China
Site Reference ID/Investigator# 43065
🇨🇳Chengdu, Sichuan, China
Site Reference ID/Investigator# 43064
🇨🇳Chengdu, Sichuan, China
Site Reference ID/Investigator# 43056
🇨🇳Beijing, China
Site Reference ID/Investigator# 43060
🇨🇳Beijing, China
Site Reference ID/Investigator# 46406
🇨🇳Beijing, China
Site Reference ID/Investigator# 43058
🇨🇳Beijing, China
Site Reference ID/Investigator# 44382
🇨🇳Beijing, China
Site Reference ID/Investigator# 43059
🇨🇳Beijing, China
Site Reference ID/Investigator# 43063
🇨🇳Beijing, China
Site Reference ID/Investigator# 43062
🇨🇳Beijing, China
Site Reference ID/Investigator# 43061
🇨🇳Beijing, China
Site Reference ID/Investigator# 43057
🇨🇳Beining, China
Site Reference ID/Investigator# 44384
🇨🇳Daqing, China
Site Reference ID/Investigator# 44383
🇨🇳Guangzhou, China
Site Reference ID/Investigator# 43074
🇨🇳Guangzhou, China
Site Reference ID/Investigator# 43067
🇨🇳Harbin, China
Site Reference ID/Investigator# 43015
🇨🇳Shanghai, China
Site Reference ID/Investigator# 43051
🇨🇳Jiangsu, China
Site Reference ID/Investigator# 43017
🇨🇳Shanghai, China
Site Reference ID/Investigator# 41554
🇨🇳Shanghai, China
Site Reference ID/Investigator# 46405
🇨🇳Shanghai, China
Site Reference ID/Investigator# 43012
🇨🇳Shanghai, China
Site Reference ID/Investigator# 43014
🇨🇳Shanghai, China
Site Reference ID/Investigator# 43011
🇨🇳Shanghai, China
Site Reference ID/Investigator# 46404
🇨🇳Shanghai, China
Site Reference ID/Investigator# 43018
🇨🇳Shanghai, China
Site Reference ID/Investigator# 43069
🇨🇳Wuhan, Hubei, China
Site Reference ID/Investigator# 43052
🇨🇳Zhejiang, China
Site Reference ID/Investigator# 43053
🇨🇳Zhejiang, China